These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
474 related items for PubMed ID: 23620425
1. Sodium hyaluronate decreases ocular surface toxicity induced by benzalkonium chloride-preserved latanoprost: an in vivo study. Yu F, Liu X, Zhong Y, Guo X, Li M, Mao Z, Xiao H, Yang S. Invest Ophthalmol Vis Sci; 2013 May 09; 54(5):3385-93. PubMed ID: 23620425 [Abstract] [Full Text] [Related]
2. [Protection effect of sodium hyaluronate on ocular surface toxicity induced by Benzalkonium chloride-preserved brimonidine in rabbits]. Yu FF, Liu X, Zhong YM, Mao Z, Guo XX, Li M, Cao D, Chen XX. Zhonghua Yan Ke Za Zhi; 2013 Nov 09; 49(11):973-80. PubMed ID: 24512997 [Abstract] [Full Text] [Related]
3. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions. Liang H, Brignole-Baudouin F, Riancho L, Baudouin C. Ophthalmic Res; 2012 Nov 09; 48(2):89-101. PubMed ID: 22473057 [Abstract] [Full Text] [Related]
4. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride. Xiong C, Chen D, Liu J, Liu B, Li N, Zhou Y, Liang X, Ma P, Ye C, Ge J, Wang Z. Invest Ophthalmol Vis Sci; 2008 May 09; 49(5):1850-6. PubMed ID: 18436819 [Abstract] [Full Text] [Related]
5. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears. Kahook MY, Noecker RJ. Cornea; 2008 Apr 09; 27(3):339-43. PubMed ID: 18362664 [Abstract] [Full Text] [Related]
6. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation. Pauly A, Roubeix C, Liang H, Brignole-Baudouin F, Baudouin C. Invest Ophthalmol Vis Sci; 2012 Dec 13; 53(13):8172-80. PubMed ID: 23150620 [Abstract] [Full Text] [Related]
7. Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma Medications. Liu X, Yu FF, Zhong YM, Guo XX, Mao Z. Chin Med J (Engl); 2015 Sep 20; 128(18):2444-9. PubMed ID: 26365960 [Abstract] [Full Text] [Related]
8. Effects of SofZia-preserved travoprost and benzalkonium chloride-preserved latanoprost on the ocular surface -- a multicentre randomized single-masked study. Aihara M, Oshima H, Araie M, EXTraKT study group. Acta Ophthalmol; 2013 Feb 20; 91(1):e7-e14. PubMed ID: 23241328 [Abstract] [Full Text] [Related]
9. In vitro and in vivo evaluation of a preservative-free cationic emulsion of latanoprost in corneal wound healing models. Liang H, Baudouin C, Daull P, Garrigue JS, Buggage R, Brignole-Baudouin F. Cornea; 2012 Nov 20; 31(11):1319-29. PubMed ID: 22929154 [Abstract] [Full Text] [Related]
10. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo. Pellinen P, Huhtala A, Tolonen A, Lokkila J, Mäenpää J, Uusitalo H. Curr Eye Res; 2012 Feb 20; 37(2):145-54. PubMed ID: 22049909 [Abstract] [Full Text] [Related]
11. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Pisella PJ, Debbasch C, Hamard P, Creuzot-Garcher C, Rat P, Brignole F, Baudouin C. Invest Ophthalmol Vis Sci; 2004 May 20; 45(5):1360-8. PubMed ID: 15111589 [Abstract] [Full Text] [Related]
12. Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride. Liang H, Baudouin C, Pauly A, Brignole-Baudouin F. Br J Ophthalmol; 2008 Sep 20; 92(9):1275-82. PubMed ID: 18723745 [Abstract] [Full Text] [Related]
13. Changes in rabbit corneal innervation induced by the topical application of benzalkonium chloride. Chen W, Zhang Z, Hu J, Xie H, Pan J, Dong N, Liu Z. Cornea; 2013 Dec 20; 32(12):1599-606. PubMed ID: 24113372 [Abstract] [Full Text] [Related]
14. Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost. Aihara M, Otani S, Kozaki J, Unoki K, Takeuchi M, Minami K, Miyata K. J Glaucoma; 2012 Jan 20; 21(1):60-4. PubMed ID: 21278589 [Abstract] [Full Text] [Related]
15. In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost. Baudouin C, Riancho L, Warnet JM, Brignole F. Invest Ophthalmol Vis Sci; 2007 Sep 20; 48(9):4123-8. PubMed ID: 17724196 [Abstract] [Full Text] [Related]
19. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F. Invest Ophthalmol Vis Sci; 2005 Jul 20; 46(7):2444-50. PubMed ID: 15980234 [Abstract] [Full Text] [Related]
20. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells. Ammar DA, Noecker RJ, Kahook MY. Adv Ther; 2010 Nov 20; 27(11):837-45. PubMed ID: 20931366 [Abstract] [Full Text] [Related] Page: [Next] [New Search]